Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116918) titled 'To assess the effect of test product in lean and obese adults with Diabetes' on Sept. 3.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Multiple Arm Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Pre-numbered or coded identical Containers Blinding and masking:Open Label
Primary Sponsor: Finzelberg GmbH and Co. KG
Condition:
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Intervention:
Intervention1: Glimepiride 1 to 3mg and Recovera 600 mg: Glimepiride will be orally once daily before...